300 related articles for article (PubMed ID: 31435529)
1. The IncRNA BORG: A novel inducer of TNBC metastasis, chemoresistance, and disease recurrence.
Gooding AJ; Parker KA; Valadkhan S; Schiemann WP
J Cancer Metastasis Treat; 2019; 5():. PubMed ID: 31435529
[TBL] [Abstract][Full Text] [Related]
2. The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers.
Gooding AJ; Zhang B; Gunawardane L; Beard A; Valadkhan S; Schiemann WP
Oncogene; 2019 Mar; 38(12):2020-2041. PubMed ID: 30467380
[TBL] [Abstract][Full Text] [Related]
3. lncRNA BORG:TRIM28 Complexes Drive Metastatic Progression by Inducing α6 Integrin/CD49f Expression in Breast Cancer Stem Cells.
Parker KA; Gooding AJ; Valadkhan S; Schiemann WP
Mol Cancer Res; 2021 Dec; 19(12):2068-2080. PubMed ID: 34497119
[TBL] [Abstract][Full Text] [Related]
4. The lncRNA BORG Drives Breast Cancer Metastasis and Disease Recurrence.
Gooding AJ; Zhang B; Jahanbani FK; Gilmore HL; Chang JC; Valadkhan S; Schiemann WP
Sci Rep; 2017 Oct; 7(1):12698. PubMed ID: 28983112
[TBL] [Abstract][Full Text] [Related]
5. Gene expression analysis to detect disseminated tumor cells in the bone marrow of triple-negative breast cancer patients predicts metastatic relapse.
Siddappa CM; Pillai SG; Snider J; Alldredge P; Trinkaus K; Watson MA; Aft R
Breast Cancer Res Treat; 2019 Nov; 178(2):317-325. PubMed ID: 31432366
[TBL] [Abstract][Full Text] [Related]
6. NOTCH3 expression is linked to breast cancer seeding and distant metastasis.
Leontovich AA; Jalalirad M; Salisbury JL; Mills L; Haddox C; Schroeder M; Tuma A; Guicciardi ME; Zammataro L; Gambino MW; Amato A; Di Leonardo A; McCubrey J; Lange CA; Liu M; Haddad T; Goetz M; Boughey J; Sarkaria J; Wang L; Ingle JN; Galanis E; D'Assoro AB
Breast Cancer Res; 2018 Sep; 20(1):105. PubMed ID: 30180881
[TBL] [Abstract][Full Text] [Related]
7. Long Non-Coding RNA (lncRNA) BMP/OP-Responsive Gene (BORG) Promotes Development of Chemoresistance of Colorectal Cancer Cells to Carboplatin.
Li J; Ma J; Zhang X; Tai X; Liu L; Zhang L
Med Sci Monit; 2020 Jan; 26():e919103. PubMed ID: 31937750
[TBL] [Abstract][Full Text] [Related]
8. Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase.
Liu R; Su S; Xing J; Liu K; Zhao Y; Stangis M; Jacho DP; Yildirim-Ayan ED; Gatto-Weis CM; Chen B; Li X
J Exp Clin Cancer Res; 2023 Oct; 42(1):264. PubMed ID: 37821954
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic Profiling Reveals Novel Candidate Genes and Signalling Programs in Breast Cancer Quiescence and Dormancy.
Quayle LA; Spicer A; Ottewell PD; Holen I
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439077
[TBL] [Abstract][Full Text] [Related]
10. Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells.
Sauer S; Reed DR; Ihnat M; Hurst RE; Warshawsky D; Barkan D
Front Oncol; 2021; 11():659963. PubMed ID: 33987095
[TBL] [Abstract][Full Text] [Related]
11. Autophagy in breast cancer metastatic dormancy: Tumor suppressing or tumor promoting functions?
Flynn AB; Schiemann WP
J Cancer Metastasis Treat; 2019; 5():. PubMed ID: 31431926
[TBL] [Abstract][Full Text] [Related]
12. The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer.
Wang W; Rana PS; Markovic V; Sossey-Alaoui K
Breast Cancer Res; 2023 Mar; 25(1):31. PubMed ID: 36949468
[TBL] [Abstract][Full Text] [Related]
13. Ecology and evolution of dormant metastasis.
Blasco MT; Espuny I; Gomis RR
Trends Cancer; 2022 Jul; 8(7):570-582. PubMed ID: 35370115
[TBL] [Abstract][Full Text] [Related]
14. Triple Negative Breast Cancer: A Mountain Yet to Be Scaled Despite the Triumphs.
Wu Q; Siddharth S; Sharma D
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359598
[TBL] [Abstract][Full Text] [Related]
15. Newly identified lncRNA-45 promotes breast cancer metastasis through activating the mTOR signaling pathway.
Qiu J; Guo Y; Wang S; Ren Q; Dong Z; Gao M; Ma J; Chen S; Liu S
Biochem Biophys Res Commun; 2023 Jan; 640():40-49. PubMed ID: 36502630
[TBL] [Abstract][Full Text] [Related]
16. NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients.
Borgen E; Rypdal MC; Sosa MS; Renolen A; Schlichting E; Lønning PE; Synnestvedt M; Aguirre-Ghiso JA; Naume B
Breast Cancer Res; 2018 Oct; 20(1):120. PubMed ID: 30322396
[TBL] [Abstract][Full Text] [Related]
17. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
18. Cell-intrinsic survival signals. The role of autophagy in metastatic dissemination and tumor cell dormancy.
Vera-Ramirez L
Semin Cancer Biol; 2020 Feb; 60():28-40. PubMed ID: 31400500
[TBL] [Abstract][Full Text] [Related]
19. The role of RNA processing and regulation in metastatic dormancy.
Parker KA; Robinson NJ; Schiemann WP
Semin Cancer Biol; 2022 Jan; 78():23-34. PubMed ID: 33775829
[TBL] [Abstract][Full Text] [Related]
20. Diabetes regulated anti-inflammatory lncRNA is overexpressed in triple-negative breast cancer and predicts chemoresistance and tumor recurrence.
Wang P; Peng W; Peng J
Bioengineered; 2022 May; 13(5):12718-12725. PubMed ID: 35609326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
